Shares in Jaguar Animal Health, Inc. (JAGX) an animal health company focused on developing and commercializing first-in-class gastrointestinal products has had a sizzling 2017 and its run continues today. The company focuses on companion and production animals, foals, and high value horses, and they recently announced the publication of a study titled “Prophylactic use of a standardized botanical extract for the prevention of naturally occurring diarrhea in newborn Holstein calves” in the official journal of the American Dairy Science Association, Journal of Dairy Science—a leading peer-reviewed general dairy research journal. The study was conducted by researchers from Cornell University College of Veterinary Medicine. Jaguar plans to launch the prophylactic formulation of Neonorm Calf this year in powder form for administration in liquid.
Neonorm Calf, one of Jaguar’s lead non-prescription products, has been formulated and clinically tested to help proactively retain fluid in dairy calves and reduce the severity of diarrhea—aiding the animals in avoiding debilitating, dangerous levels of dehydration associated with scours. The powder form of the product allows for ease of administration for herd-wide management.
See a 3 month chart below for JAGX (cover photo attribute to Wikipedia)
We will be rolling our our portfolio in upcoming weeks one sector at a time…sign up below or ping us at the email below.
Email me [email protected] if you are a Public Company and would like to see our Testimonials
Click Here if you are an Investor and want to sign up for our Friday Newsletter
Click Here to be part of the Equities.com Database you can also reach us at [email protected]